BAC-FISH refutes report of an 8p22–8p23.1 inversion or duplication in 8 patients with Kabuki syndrome
© Kimberley et al; licensee BioMed Central Ltd. 2006
Received: 06 January 2006
Accepted: 18 May 2006
Published: 18 May 2006
Kabuki syndrome is a multiple congenital anomaly/mental retardation syndrome. The syndrome is characterized by varying degrees of mental retardation, postnatal growth retardation, distinct facial characteristics resembling the Kabuki actor's make-up, cleft or high-arched palate, brachydactyly, scoliosis, and persistence of finger pads. The multiple organ involvement suggests that this is a contiguous gene syndrome but no chromosomal anomalies have been isolated as an etiology. Recent studies have focused on possible duplications in the 8p22–8p23.1 region but no consensus has been reached.
We used bacterial artificial chromosome-fluorescent in-situ hybridization (BAC-FISH) and G-band analysis to study eight patients with Kabuki syndrome.
Metaphase analysis revealed no deletions or duplications with any of the BAC probes. Interphase studies of the Kabuki patients yielded no evidence of inversions when using three-color FISH across the region. These results agree with other research groups' findings but disagree with the findings of Milunsky and Huang.
It seems likely that Kabuki syndrome is not a contiguous gene syndrome of the 8p region studied.
Kabuki syndrome [OMIM 147920] is a multiple congenital anomaly/mental retardation syndrome of unknown etiology. The syndrome was first described independently by Niikawa et. al. and Kuroki et. al. in 1981 [1, 2]. There is no definitive laboratory diagnostic test for Kabuki syndrome, thus diagnosis is made based on phenotypic presentation and by ruling out other known syndromes. The typical characteristics of Kabuki syndrome are: varying degrees of mental retardation, postnatal growth retardation, characteristic dysmorphic facial features, congenital heart disease, brachydactyly, scoliosis, and persistence of prominent finger pads.
The dysmorphic facies are characterized by long palpebral fissures with eversion of the lateral part of the lower eyelids, arched eyebrows, broad, depressed nasal tip, prominent ears, cleft or high-arched palate, and dental/occlusal abnormalities. Individuals with Kabuki syndrome have relative strengths in verbal and reasoning abilities and weakness in visuospatial construction; adaptive behavior is characterized by good social interactions and communication but poor motor and personal living skills . The multiple organ involvement suggests that Kabuki syndrome is a contiguous gene syndrome but no etiology has been determined. There have been several cases of Kabuki syndrome with various chromosomal anomalies but none have had any cytogenetic anomaly in common [4–6]. Milunsky and Huang  recently reported finding a duplication of 8p22–8p23.1 in six unrelated patients with Kabuki syndrome. They also reported finding a submicroscopic inversion in all six patients and in two mothers of Kabuki syndrome children. However, studies conducted by Miyake et. al. , Schoumans et. al. , Miyake et. al. , Hoffman et. al. , Engelen et. al. , Sanlaville et. al. , and Turner et. al.  failed to find evidence of the duplications reported by Milunsky and Huang. We investigated eight patients with Kabuki syndrome and six normal controls to determine if either an inversion or a duplication in 8p22–8p23.1 exists.
Eight individuals with Kabuki syndrome identified through the University of Nevada School of Medicine Genetics Program consented to participate in the study. Medical records were reviewed and physical examinations were completed. The diagnosis was based upon the presence of the typical pattern of malformations and dysmorphic features reviewed by Matsumoto and Niikawa .
Blood was collected from patients diagnosed with Kabuki syndrome, their parents, and normal controls according to approved Institutional Review Board procedures. Blood lymphocytes were cultured using standard cytogenetic techniques with thymidine used for synchronization. The lymphocytes were dropped onto clean, wet slides to obtain well spread metaphase chromosomes and interphase nuclei. The slides were allowed to air dry and were then baked for 1 ½ hours at 90°C. Analysis of metaphase chromosomes occurred by using GTG-banding standard techniques.
Fluorescent in-situhybridization (FISH)
Ten bacterial artificial chromosome (BAC) clones that both Milunsky and Huang  and Miyake et. al.  reportedly used (RP11-11P7, RP11-140K14, RP11-122N11, RP11-235F10, RP11-112G9, RP11-252K12, RP11-31B7, RP11-92C1, RP11-23H1, and RP11-141K9) were obtained from the Children's Hospital Oakland Research Institute (Oakland, CA) human genomic library. The BACs were grown and the DNA harvested using standard methods. The ends of the BAC DNA insert were sequenced at the Nevada Genomics Center at the University of Nevada, Reno, NV. The sequences were compared to published NCBI genomic sequences using the BLAST program to confirm the location of the BAC DNA on the human genome.
The BAC DNA was then labeled separately in both Spectrum Red and Spectrum Green using a Nick Translation Kit (Vysis, Downers Grove, IL). The labeled DNA was co-precipitated with Human Hybloc (Cot-1) DNA (Applied Genetics Laboratories, Melborne, FL) and tested on normal control slides to confirm labeling success.
To detect inversions, three-color FISH was performed by applying probes labeled in Spectrum Red and Spectrum Green. The third color, yellow, was achieved by mixing equal parts of red and green labeled probe. Prepared slides of both Kabuki patients and normal controls were serially dehydrated in ethanol and allowed to air dry. Labeled BAC probe was applied. The slides were coverslipped and sealed with rubber cement. Co-denaturation of probe and target DNA occurred at 77.5°C for 6 minutes followed by hybridization at 37°C overnight. The coverslips were removed and the slides washed in 50% formamide/2X SSC at 50°C for 15 minutes followed by a wash in 2X SSC at 37°C for 8 minutes to remove any mismatched probe. The slides were air dried, counterstained with DAPI/Antifade, coverslipped, and sealed. The slides were then examined by fluorescence microscopy and scored for probe number and probe order.
Results and discussion
Kabuki syndrome clinical features. The clinical features of the eight Kabuki patients included in this study.
Age of Dx
IgA and IgG deficiency
Five or more cells were analyzed for each patient following U.S. clinical cytogenetic standards. No cytogenetic abnormalities were noted by either G-band analysis of at least the 500-band level resolution or by targeted high resolution analysis of 8pter of the Kabuki patients.
The BAC probes were tested against normal controls to confirm the probe location and signal number. Except BAC RP11-122N11, all BAC probes showed two equally strong signals on all metaphases and interphase nuclei. BAC RP11-122N11 showed four or five signals on all control metaphases and interphases and was rejected for use in this study. Interestingly, this BAC was reported by Milunsky and Huang as being inverted in their Kabuki patients . Hollox et. al.  and Sanlaville et. al.  have mapped this BAC to the middle of the β-defensin-gene cluster, a gene cluster that is polymorphic for copy number, corresponding to gene SPAG11 at 8p23.1. This BAC also matched with multiple loci on multiple chromosomes when the sequenced ends were compared to known human genomic sequences using the NCBI BLAST program.
The remaining nine BAC probes were tested on eight Kabuki syndrome probands. All probes yielded two equally strong signals on both metaphase chromosomes and interphase nuclei indicating no deletion or duplication of these probes. This supports the recent findings of three genome-wide array CGH screenings that did not reveal any pathological findings in Kabuki patients, indicating that microduplications or microdeletions are less likely to be the cause of Kabuki syndrome [5, 6, 9].
To date, we have been unable to find evidence of any inversions, duplications, or deletions in the 8p22–8p23.1 region as reported by Milunsky and Huang . Our results are consistent with those reported by Miyake et. al. , Schoumans et. al. , Miyake et. al. , Hoffman et. al. , Engelen et. al. , Sanlaville et. al. , and Turner et. al. . The discrepancy that exists among the groups could be attributed to two possible scenarios: 1) the patients studied by Milunsky and Huang represent either a variant of Kabuki syndrome or a different syndrome of similar phenotypic characteristics (phenocopy), or 2) the reported duplication represents a normal variant in the 8p region as this region is known to undergo genetic rearrangement due to olfactory receptor-gene clusters causing unequal crossovers [6, 11]; none of these genetic rearrangements have been associated with any clinical pathology. Further studies, possibly with collaboration between the groups, are required to determine why the discrepancies in the research results exist. However, it now seems less likely that Kabuki syndrome is caused by a contiguous gene rearrangement than by a mutation in a regulatory gene.
We would like to thank Cecilia Rios for her technical help setting up the laboratory experiments, and all of the families that participated in this study.
Funded by NIH grant R01NS35102 to Carolyn Mervis.
- Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T: Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. Journal of Pediatrics. 1981, 99: 565-569. 10.1016/S0022-3476(81)80255-7.View ArticlePubMedGoogle Scholar
- Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I: A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. Journal of Pediatrics. 1981, 99: 570-573. 10.1016/S0022-3476(81)80256-9.View ArticlePubMedGoogle Scholar
- Mervis CB, Becerra AM, Rowe ML, Hersh JH, Morris CA: Intellectual abilities and adaptive behavior of children and adolescents with Kabuki syndrome: a preliminary study. American Journal of Medical Genetics. 2005, 132A: 248-255. 10.1002/ajmg.a.30334.View ArticlePubMedGoogle Scholar
- Armstrong L, El Moneim AA, Aleck K, Aughton DJ, Baumann C, Braddock SR, Gillessen-Kaesbach G, Graham JM, Grebe TA, Gripp KW, Hall BD, Hennekam R, Hunter A, Keppler-Noreuil K, Lacombe D, Lin AE, Ming JE, Kokitsu-Nakata NM, Nikkel SM, Philip N, Raas-Rothschild A, Sommer A, Verloes A, Walter C, Wieczorek D, Williams MS, Zackai E, Allanson JE: Further delineation of Kabuki syndrome in 48 well-defined new individuals. American Journal of Medical Genetics. 2005, 132A: 265-272. 10.1002/ajmg.a.30340.View ArticlePubMedGoogle Scholar
- Miyake N, Shimokawa O, Harada N, Sosonkina N, Okubo A, Kawara H, Okamoto N, Ohashi H, Kurosawa K, Naritomi K, Kaname T, Nagai T, Shotelersuk V, Hou JW, Fukushima Y, Kondoh T, Matsumoto T, Shinoki T, Kato M, Tonoki H, Nomura M, Yoshiura KI, Kishino T, Ohta T, Niikawa N, Matsumoto N: No detectable genomic aberrations by BAC array CGH in Kabuki make-up syndrome patients. American Journal of Medical Genetics. 2006, 140A: 291-293. 10.1002/ajmg.a.31012.View ArticleGoogle Scholar
- Schoumans J, Nordgren A, Ruivenkamp C, Brondum-Nielsen K, Teh BT, Anneren G, Holmberg E, Nordenskjold M, Anderlid BM: Genome-wide screening using array-CGH does not reveal microdeletions/microduplications in children with Kabuki syndrome. European Journal of Human Genetics. 2005, 13: 260-263. 10.1038/sj.ejhg.5201309.View ArticlePubMedGoogle Scholar
- Milunsky JM, Huang XL: Unmasking Kabuki syndrome: chromosome 8p22–8p23.1 duplication revealed by comparative genomic hybridization and BAC-FISH. Clinical Genetics. 2003, 64: 509-516. 10.1046/j.1399-0004.2003.00189.x.View ArticlePubMedGoogle Scholar
- Miyake N, Harada N, Shimokawa O, Ohashi H, Kurosawa K, Matsumoto T, Fukushima Y, Nagai T, Shotelersuk V, Yoshiura K, Ohta T, Kishino T, Niikawa N, Matsumoto N: On the reported 8p22-p23.1 duplication in Kabuki make-up syndrome (KMS) and its absence in patients with typical KMS. American Journal of Medical Genetics. 2004, 128A: 170-172. 10.1002/ajmg.a.30137.View ArticlePubMedGoogle Scholar
- Hoffman JD, Zhang Y, Greshock J, Ciprero KL, Emanuel BS, Zackai EH, Weber BL, Ming JE: Array based CGH and FISH fail to confirm duplication of 8p22-p23.1 in association with Kabuki syndrome. Journal of Medical Genetics. 2005, 42: 49-53. 10.1136/jmg.2004.024372.View ArticlePubMedPubMed CentralGoogle Scholar
- Engelen JJM, Loneus WH, Vaes-Peeters G, Schrander-Stumpel CTRM: Kabuki syndrome is not caused by an 8p duplication: a cytogenetic study in 20 patients. American Journal of Medical Genetics. 2005, 132A: 276-277. 10.1002/ajmg.a.30457.View ArticlePubMedGoogle Scholar
- Sanlaville D, Genevieve D, Bernardin C, Amiel J, Baumann C, de Blois MC, Cormier-Daire V, Gerard B, Gerard M, Le Merrer M, Parent P, Prieur F, Prieur M, Raoul O, Toutain A, Verloes A, Viot G, Romana S, Munnich A, Lyonnet S, Vekemans M, Turleau C: Failure to detect an 8p22–8p23.1 duplication in patients with Kabuki (Niikawa-Kuroki) syndrome. European Journal of Human Genetics. 2005, 13: 690-693. 10.1038/sj.ejhg.5201383.View ArticlePubMedGoogle Scholar
- Turner C, Lachlan K, Amerasinghe N, Hodgkins P, Maloney V, Barber J, Temple IK: Kabuki syndrome: new ocular findings but no evidence of 8p22-p23.1 duplications in a clinically defined cohort. European Journal of Human Genetics. 2005, 13: 716-720. 10.1038/sj.ejhg.5201377.View ArticlePubMedGoogle Scholar
- Matsumoto N, Niikawa N: Kabuki make-up syndrome: a review. American Journal of Medical Genetics. 2003, 117C: 57-65. 10.1002/ajmg.c.10020.View ArticlePubMedGoogle Scholar
- Hollox EJ, Armour JAL, Barber JCK: Extensive normal copy number variation of a β-defensin antimicrobial-gene cluster. American Journal of Human Genetics. 2003, 73: 591-600. 10.1086/378157.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/7/46/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.